Frequency and distribution of primary site among gender minority cancer patients: An analysis of U.S. national surveillance data.
Frequency and distribution of primary site among gender minority cancer patients: An analysis of U.S. national surveillance data.
复制标题
DOI:
10.1016/j.canep.2018.02.008
复制
发表时间:
2018-06
影响因子:
2.6
通讯作者:
Goodman M
中科院分区:
文献类型:
--
作者:
Nash R;Ward KC;Jemal A;Sandberg DE;Tangpricha V;Goodman M
Transgender people and persons with disorders of sex development (DSD) are two separate categories of gender minorities, each characterized by unique cancer risk factors. Although cancer registry data typically include only two categories of sex, registrars have the option of indicating that a patient is transgender or has a DSD. Data for primary cancer cases in 46 states and the District of Columbia were obtained from the North American Association of Central Cancer Registries (NAACCR) database for the period 1995–2013. The distributions of primary sites and categories of cancers with shared risk factors were examined separately for transgender and DSD patients and compared to the corresponding distributions observed in male and female cancer patients. Proportional incidence ratios were calculated by dividing the number of observed cases by the number of expected cases. Expected cases were calculated based on the age- and year of diagnosis-specific proportions of cases for each cancer category observed among male and female patients. Transgender patients have significantly elevated proportional incidence ratios (95% confidence intervals) for viral infection induced cancers compared to either males (2.3; 2.0–2.7) or females (3.3; 2.8–3.7). Adult DSD patients have a similar distribution of cancer sites compared to male or female patients but DSD children have ten times more cases of testicular cancer than expected (95% confidence interval: 4.7–20). The proportions of certain primary sites and categories of malignancies among transgender and DSD cancer patients are different from the proportions observed for male or female patients.
登录
查看更多内容
DOI:
10.1016/j.ogc.2009.02.001
发表时间:
2009-03-01
影响因子:
3.2
作者:
Allen, Lisa
通讯作者:
Allen, Lisa
影响因子:
2.3
作者:
Pleskacova, J.;Hersmus, R.;Looijenga, L. H.
通讯作者:
Looijenga, L. H.
影响因子:
5.8
作者:
Cools, M.;Pleskacova, J.;Wolffenbuttel, K. P.
通讯作者:
Wolffenbuttel, K. P.
影响因子:
2
作者:
Jiang, Jian-Fa;Xue, Wei;Sun, Ai-Jun
通讯作者:
Sun, Ai-Jun
影响因子:
5.6
作者:
Silverberg, Michael J.;Nash, Rebecca;Goodman, Michael
通讯作者:
Goodman, Michael